About 1 result found for searched term "851627-62-8" (0.125 seconds)
Cat.No. | Name | Target |
---|---|---|
M25447 | PR-104 | DNA/RNA Synthesis |
PR-104 is a novel hypoxia-activated DNA cross-linking agent with marked activity against human tumor xenografts, both as monotherapy and combined with radiotherapy and chemotherapy. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.